Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Apellis Pharmaceuticals Inc (APLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Norwich University Applied Research Institutes Partners with Tokyo's Allied Telesis to Provide Cutting-Edge Cybersecurity Education and Training Courses

With the goal of strengthening its security-related business, Tokyo's Allied Telesis K.K. has partnered exclusively with Norwich University to launch a new slate of cybersecurity education and training...

INOTF : 0.0671 (+9.82%)
APLS : 20.23 (+2.90%)
Guy Sauvageau and Josée Hébert, winners of the 2017 Genome Canada "Genomics and Precision Health "competition

Guy Sauvageau and Josée Hébert, winners of the 2017 Genome Canada "Genomics and Precision Health "competition

APLS : 20.23 (+2.90%)
Bihrle Applied Research Inc. announces Ardenna, a New Venture Focused on Computer Vision and Machine Learning Solutions for Infrastructure Inspections

On the heels of its groundbreaking success with BNSF Railway in the achievement of truly automated long-range UAS supplemental track inspections, Bihrle Applied Research (Bihrle) announced today that it...

APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals Announces Closing of Offering of Common Stock

Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement...

APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock

Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement...

APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals Announces Proposed Offering of Common Stock

Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement...

APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals Provides Update on Phase 1b Open Label Study of APL-2 in PNH Patients Not Previously Treated with Eculizumab

Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of autoimmune and inflammatory diseases,...

APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

- Initiation of Phase 3 Programs in Geographic Atrophy (GA) and Paroxysmal Nocturnal Hemoglobinuria (PNH) Planned for 2018; Phase 2 Proof-of-Concept (POC) Data Anticipated in Autoimmune Hemolytic Anemia...

APLS : 20.23 (+2.90%)
Alltemp Outperforms 6 Major Refrigerants in Applied Research Laboratories Tests

ARL Testing Shows Alltemp Refrigerants Superior to MO-99, Nu22, 407c, R-404a, 134a, and 448a(M40)

APLS : 20.23 (+2.90%)
LTMP : 0.1163 (+5.73%)
Tech-Access Canada Welcomes Strong Support for College Applied Research

Tech-Access Canada, the national network of Canada's 30 Technology Access Centres (TACs), welcomes Budget 2018 initiatives to support innovation and applied research at Canada's colleges and cégeps.

APLS : 20.23 (+2.90%)
Healthcare Innovation Expert Appointed to Timicoin Advisory Board

Timicoin (www.Timicoin.io), world's first cryptocurrency mobile platform to use blockchain technology for storing and accessing medical records, announced Joyce Lignell, former Vice President Business...

APLS : 20.23 (+2.90%)
The World's First Electronic Communication Network For Digital Currencies Announces Collaboration with Seneca College

Blockstation ("The Company"), a Blockchain token reference quote, delivery system, and electronic communications network company announces a collaboration with Seneca Applied Research and Innovation alongside...

APLS : 20.23 (+2.90%)
Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease

Biotagenics Inc., a microbiome-based platform company developing novel therapeutics and diagnostics is the industrial collaborator on a $9.1 million CAD ($7.4 million USD) project led by academic collaborators...

APLS : 20.23 (+2.90%)
NSF AuthenTechnologies® Looks to 2018 With New Leadership

In a move meant to more closely align its California-based DNA testing lab with NSF International's core scientific testing and research services, the global public health organization recently appointed...

APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference

Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, today announced that...

JPM : 111.23 (-1.12%)
APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals Expands Management Team, Appoints Timothy Sullivan Chief Financial Officer

Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, announced today the...

APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) to Ring The Nasdaq Stock Market Closing Bell

What:

NDAQ : 92.61 (+0.78%)
APLS : 20.23 (+2.90%)
Apellis Pharmaceuticals Presents Update on Phase 1b PHAROAH Trial of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) at Annual Scientific Assembly of the International PNH Interest Group (IPIG)

Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, will present an update...

APLS : 20.23 (+2.90%)
TCS & Cornell Tech Inaugurate the Tata Innovation Center, Partnership on Campus to Promote Joint Academic and Industry Research

Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading global IT services, consulting and business solutions organization, announced December 4 a $50 million investment in Cornell Tech. The...

APLS : 20.23 (+2.90%)
ARA to Demo Advanced Warfighter Technologies at I/ITSEC 2017

The Virtual Heroes Division of Applied Research Associates (ARA) will demo their latest 3D virtual world software at the 2017 Interservice/Industry Training, Simulation and Education Conference (I/ITSEC)....

APLS : 20.23 (+2.90%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar